Antengene Corporation Limited (6996.HK)

HKD 3.03

(1.0%)

EBITDA Summary of Antengene Corporation Limited

  • Antengene Corporation Limited's latest annual EBITDA in 2023 was -550.31 Million CNY , up 36.4% from previous year.
  • Antengene Corporation Limited's latest quarterly EBITDA in 2024 Q2 was -184.94 Million CNY , down 0.0% from previous quarter.
  • Antengene Corporation Limited reported an annual EBITDA of -866.05 Million CNY in 2022, down -40.98% from previous year.
  • Antengene Corporation Limited reported an annual EBITDA of -614.31 Million CNY in 2021, down -22.39% from previous year.
  • Antengene Corporation Limited reported a quarterly EBITDA of -345.38 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • Antengene Corporation Limited reported a quarterly EBITDA of N/A for 2023 FY, up 36.4% from previous quarter.

Annual EBITDA Chart of Antengene Corporation Limited (2023 - 2018)

Historical Annual EBITDA of Antengene Corporation Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -550.31 Million CNY 36.4%
2022 -866.05 Million CNY -40.98%
2021 -614.31 Million CNY -22.39%
2020 -501.94 Million CNY -248.76%
2019 -143.92 Million CNY -7.38%
2018 -133.44 Million CNY 0.0%

Peer EBITDA Comparison of Antengene Corporation Limited

Name EBITDA EBITDA Difference
Uni-Bio Science Group Limited 91.23 Million HKD 703.186%
CK Life Sciences Int'l., (Holdings) Inc. 486.79 Million HKD 213.048%